GPR35-mediated metabolic reprogramming promotes tumorigenesis in digestive cancers.

Saved in:
Bibliographic Details
Title: GPR35-mediated metabolic reprogramming promotes tumorigenesis in digestive cancers.
Authors: Wang F; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Ding XX; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Su TH; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Cao J; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Li FQ; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China., Dong ZS; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China., Guo XZ; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Zhang Y; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China., Chen Y; State Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China., Yang DH; New York College of Traditional Chinese Medicine, Mineola, NY, United States., Luo P; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
Source: Frontiers in immunology [Front Immunol] 2025 Dec 12; Vol. 16, pp. 1668471. Date of Electronic Publication: 2025 Dec 12 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1668471